The spasticity landscape offers opportunities with over 10 companies and 12 pipeline drugs in development. Key prospects lie in novel therapies like Motric Bio's MTR-601 and Ipsen's IPN10200. Focused ...
Sativex, a cannabis-based spray for MS spasticity, was bought by CNX Therapeutics. It's used as an add-on therapy in Europe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback